Hofseth Biocare ASA (HBC) - Total Liabilities

Latest as of September 2025: Nkr419.19 Million NOK ≈ $44.11 Million USD

Based on the latest financial reports, Hofseth Biocare ASA (HBC) has total liabilities worth Nkr419.19 Million NOK (≈ $44.11 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Hofseth Biocare ASA - Total Liabilities Trend (2010–2024)

This chart illustrates how Hofseth Biocare ASA's total liabilities have evolved over time, based on quarterly financial data. See HBC current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Hofseth Biocare ASA Competitors by Total Liabilities

The table below lists competitors of Hofseth Biocare ASA ranked by their total liabilities.

Company	Country	Total Liabilities
Linz Textil Holding AG VI:LTH	Austria	€12.40 Million
Shenzhen SEG Co Ltd SHE:200058	China	HK$2.47 Billion
Futuretech II Acquisition Corp NASDAQ:FTII	USA	$10.38 Million
BRAIN Biotech AG XETRA:BNN	Germany	€64.50 Million
Waskita Beton Precast Tbk PT JK:WSBP	Indonesia	Rp5.05 Trillion
ICE FISH FARM AS NK-10 F:4YYA	Germany	€230.30 Million
Helixmith Co. Ltd KQ:084990	Korea	₩1.66 Billion
Deswell Industries Inc NASDAQ:DSWL	USA	$20.17 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Hofseth Biocare ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HBC company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.30	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-15.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hofseth Biocare ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hofseth Biocare ASA (2010–2024)

The table below shows the annual total liabilities of Hofseth Biocare ASA from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	Nkr280.07 Million ≈ $29.47 Million	-19.75%
2023-12-31	Nkr348.98 Million ≈ $36.72 Million	+32.69%
2022-12-31	Nkr263.00 Million ≈ $27.68 Million	-4.57%
2021-12-31	Nkr275.60 Million ≈ $29.00 Million	+41.06%
2020-12-31	Nkr195.37 Million ≈ $20.56 Million	+11.47%
2019-12-31	Nkr175.26 Million ≈ $18.44 Million	+71.99%
2018-12-31	Nkr101.90 Million ≈ $10.72 Million	-30.75%
2017-12-31	Nkr147.16 Million ≈ $15.49 Million	+39.10%
2016-12-31	Nkr105.79 Million ≈ $11.13 Million	-34.21%
2015-12-31	Nkr160.80 Million ≈ $16.92 Million	+15.75%
2014-12-31	Nkr138.92 Million ≈ $14.62 Million	-2.89%
2013-12-31	Nkr143.05 Million ≈ $15.05 Million	+32.55%
2012-12-31	Nkr107.92 Million ≈ $11.36 Million	+185.20%
2011-12-31	Nkr37.84 Million ≈ $3.98 Million	+103.55%
2010-12-31	Nkr18.59 Million ≈ $1.96 Million	--

About Hofseth Biocare ASA

OL:HBC Norway Packaged Foods

Market Cap

$51.55 Million

Nkr489.89 Million NOK

Market Cap Rank

#21857 Global

#196 in Norway

Share Price

Nkr1.24

Change (1 day)

+7.83%

52-Week Range

Nkr1.12 - Nkr2.08

All Time High

Nkr10.95